Jolt Health Company Description
Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada, the Netherlands, rest of Europe, and Jamaica.
The company focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses.
It offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for a variety of conditions.
The company also provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel.
The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023.
Jolt Health Inc. is headquartered in Vancouver, Canada.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 41 |
CEO | Gerald Tritt |
Contact Details
Address: 1780 -355 Burrard Street Vancouver, Alberta V6C 2G8 Canada | |
Phone | 604 343 2977 |
Website | jolt-health.com |
Stock Details
Ticker Symbol | JOLT |
Exchange | Canadian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
SIC Code | 7371 |
Key Executives
Name | Position |
---|---|
Gerald Spencer Tritt | President, Chief Executive Officer and Director |
Tatiana Kovaleva | Chief Financial Officer |